RVPH 0.98 (-6.67%)
US76152G1004BiotechnologyBiotechnology

Reviva Pharmaceuticals Holdings (RVPH) Stock Highlights

0.98 | -6.67%
2024-07-23 05:23:09
Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimers disease, Parkinsons disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis.

Statistics

Range Today
0.95 1.04
Volume Today 291.8K
Range 1 Year
1.04 6.8
Volume 1 Year 129.8M
Range 3 Year
0.53 9.25
Volume 3 Year 335.04M
Range 10 Year
0.53 15.1
Volume 10 Year 448.3M

Highlights

Market Capitalization 31.31M (micro)
Floating Shares 24.6M
Current Price 0.98
Price To Earnings -0.68
Earnings Per Share -1.59
Payout Ratio 0%

Performance

Latest -6.67%
1 Month -22.22%
3 Months -67.87%
6 Months -76.1%
1 Year -80.28%
3 Years -73.87%
5 Years -90.45%
10 Years -89.84%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.